PharmGen Science Inc (004720) — Cash Flow Quality Index
PharmGen Science Inc (004720) has a Cash Flow Quality Index of 0.92x as of December 2024. Operating cash flow of ₩3.40 Billion is below net income of ₩3.71 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 004720 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PharmGen Science Inc Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for PharmGen Science Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PharmGen Science Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for PharmGen Science Inc (2015–2024)
Year-by-year earnings quality comparison for PharmGen Science Inc. For live market cap and the full company financial profile, see how much is PharmGen Science Inc worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.85x | ₩2.38 Billion | ₩2.79 Billion | ▼ -4.4% |
| 2023 | 0.89x | ₩5.44 Billion | ₩6.09 Billion | ▲ +4965.7% |
| 2022 | -0.02x | ₩-1.29 Billion | ₩70.06 Billion | ▼ -107.7% |
| 2021 | 0.24x | ₩7.78 Billion | ₩32.47 Billion | ▼ -17.4% |
| 2020 | 0.29x | ₩2.68 Billion | ₩9.22 Billion | ▼ -96.5% |
| 2019 | 8.36x | ₩2.52 Billion | ₩301.98 Million | ▲ +785.7% |
| 2018 | 0.94x | ₩4.22 Billion | ₩4.47 Billion | ▲ +121.8% |
| 2017 | 0.43x | ₩1.84 Billion | ₩4.32 Billion | ▼ -81.1% |
| 2016 | 2.25x | ₩7.75 Billion | ₩3.45 Billion | ▲ +28.2% |
| 2015 | 1.75x | ₩3.62 Billion | ₩2.07 Billion | — |